Yamamoto Koichiro, Tokumasu Kazuki, Oka Kosuke, Hasegawa Kou, Otsuka Fumio
Department of General Medicine Dentistry and Pharmaceutical Sciences Okayama University Graduate School of Medicine Okayama Japan.
Clin Case Rep. 2021 Jun 10;9(6):e04305. doi: 10.1002/ccr3.4305. eCollection 2021 Jun.
We report a case of isolated adrenocorticotropin deficiency caused by pembrolizumab. This condition can be fatal, but its rarity causes under-recognition. Oncologists should pay attention to adrenal insufficiency due to pembrolizumab.
我们报告了一例由帕博利珠单抗引起的孤立性促肾上腺皮质激素缺乏症病例。这种情况可能是致命的,但因其罕见而未得到充分认识。肿瘤学家应关注帕博利珠单抗所致的肾上腺功能不全。